We are reimagining genomics
About Us
Decipher Biosciences is reimagining the use of genomic information to transform and improve cancer patient care.
We are committed to delivering the most accurate tests for determining the true nature of prostate and bladder cancers, enabling each patient to have a treatment plan based on the unique biology of their tumor.
Leadership
Tina S. Nova, Ph.D.
President and CEO
Elai Davicioni, Ph.D.
Chief Scientific Officer
Bashar Dabbas, M.D.
Chief Medical Officer and Laboratory Director
John Aballi
Chief Operating Officer
Brent Vetter, CPA
Chief Financial Officer
Ryan Dittamore
Chief Business Officer and Head of Product Development
Christopher Roberts
Senior Vice President Corporate Initiatives
Leadership
Board of Directors
Robert S. Epstein, MD MS
Chairman
Epstein Health LLCHenry Skinner, PhD
Director
TEKLATodd Holmes
Director
CRGAndrew Levitch
Director
MERCKKathy L. Hibbs, JD
Director
23andMeTina S. Nova, PhD
Director
Decipher Biosciences
Board of Directors
Join Our Team
Be a part of Decipher Biosciences, a premier provider of genomic testing for prostate and bladder cancers
Careers